Breyangi IV injection, manufactured by Bristol-Myers Squibb, contains Risocabutagen Maralucel (YJ code: 4900406X1029, per patient). This medicine is a CAR T-cell therapy, a type of immunotherapy used to treat certain blood cancers.
Breyangi IV injection
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).